1. Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A, Schurman L.Osteogenic actions of the anti-diabetic drug metformin on osteoblastsin culture. Eur J Pharmacol. 2006;536(1-2):38-46.
2. Griss T, Vincent EE, Egnatchik R, et al. Metformin antagonizescancer cell Proliferation by Suppressing mitochondrial-dependentbiosynthesis. PLoS Biol. 2005;13(12):e1002309.
3. Yanardag R, Ozsoy-Sacan O, Bolkent S, Orak H, Karabulut-BulanO. Protective effects of metformin treatment on the liver injury ofstreptozotocin-diabetic rats. Hum Exp Toxicol. 2005;24(3):129-135.
4. Correia S, Carvalho C, Santos M, Seica R, Oliveira C, Moreira P.Mechanisms of action of metformin in type 2 diabetes and associatedcomplications: an overview. Mini Rev Med Chem. 2008;8(13):1343-1354.
5. Samuel SM, Varghese E, Varghese S, Büsselberg D. Challenges andperspectives in the treatment of diabetes associated breast cancer.Cancer Treat Rev. 2018;(70):98-111.
6. Nesti L, Natali A. Metformin effects on the heart and the cardiovascularsystem: a review of experimental and clinical data. Nutr MetabCardiovasc Dis. 2017;27(8):657-669.
7. Kim EH, Kim MS, Cho CK, Jung WG, Jeong YK, Jeong JH. Low andhigh linear energy transfer radiation sensitization of HCC cells bymetformin. J Radiat Res. 2014;55(3):432-442.
8. Iranshahy M, Rezaee R, Karimi G. Hepatoprotective activity ofmetformin: a new mission for an old drug? Eur J Pharmacol. 2019;850:1-7.
9. Li Y, Liu L, Wang B, Wang J, Chen D. Metformin in non-alcoholicfatty liver disease: a systematic review and meta-analysis. Biomed Rep.2013;1(1):57-64.
10. Corremans R, Vervaet BA, D’Haese PC, Neven E, Verhulst A.Metformin: a candidate drug for renal diseases. Int J Mol Sci.2018;20(1):42.
11. Rotermund C, Machetanz G, Fitzgerald JC. The therapeutic potential ofmetformin in neurodegenerative diseases. Front Endocrinol (Lausanne).2018;(19):9.
12. Ma J, Liu J, Yu H, Chen Y, Wang Q, Xiang L. Beneficial effect ofmetformin on nerve regeneration and functional recovery after sciaticnerve crush injury in diabetic rats. Neurochem Res. 2016;41:1130-1137.
13. Mao-Ying QL, Kavelaars A, Krukowski K, et al. The anti-diabeticdrug metformin protects against chemotherapy-induced peripheralneuropathy in a mouse model. PLoS One. 2014;9(6):e100701.
14. Bahrambeigi S, Yousefi B, Rahimi M, Shafiei-Irannejad V. Metformin;an old antidiabetic drug with new potentials in bone disorders.Biomedicine & Pharmacotherapy. 2019;109:1593-1601.
15. Jang WG, Kim EJ, Bae IH, et al. Metformin induces osteoblastdifferentiation via orphan nuclear receptor SHP-mediatedtransactivation of Runx2. Bone. 2011;48(4):885-893.
16. Qin W, Gao X, Ma T, et al. Metformin enhances the differentiation ofdental pulp cells into odontoblasts by activating AMPK signaling. JEndod. 2018;44(4): 576-584.
17. Lei T, Deng S, Chen P, et al. Metformin enhances the osteogenesisand angiogenesis of human umbilical cord mesenchymal stemcells for tissue regeneration engineering. Int J Biochem Cell Biol.2021;141:106086.
18. Molinuevo S, Schurman L, Mccarthy AD, et al. Effect of metforminon bone marrow progenitor cell differentiation: in vivo and In vitrostudies. J Bone Miner Res. 2010;25(2): 211-221.
19. Haugrud AB, Zhuang Y, Coppock JD, Miskimins WK. Dichloroacetateenhances apoptotic cell death via oxidative damage and attenuateslactate production in metformin-treated breast cancer cells. BreastCancer Res Treat. 2014;147(3):539-550.
20. Koritzinsky M. Metformin: a novel biological modifier of tumorresponse to radiation therapy. Int J Radiat Oncol Biol Phys.2015;93(2):454-464.
21. Scheide D, Huber R, Friedrich T. The proton-pumpingNADH:ubiquinone oxidoreductase (complex I) of Aquifex aeolicus.FEBS Lett. 2002;512(1-3):80-84.
22. Friedrich T, Scheide D. The respiratory complex I of bacteria, archaeaand eukarya and its module common with membrane-boundmultisubunit hydrogenases. FEBS Lett. 2000;479(1-2):1-5.
23. Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK)controls the aging process via an integrated signaling network. AgeingRes Rev. 2012;11(2):230-241.
24. Hur KY, Lee MS. New mechanisms of metformin action: Focusing onmitochondria and the gut. J Diabetes Investig. 2015;6(6):600-609.
25. Bae HB, Zmijewski JW, Deshane JS, et al. AM Pactivated protein kinaseenhances the phagocytic ability of macrophages and neutrophils. FasebJ. 2011;25(12):4358-4368.
26. Wang S, Xia Y, Ma T, et al. Novel metformin-containing resin promotesodontogenic differentiation and mineral synthesis of dental pulp stemcells. Drug Deliv Transl Research. 2019;(9):85-96.
27. Houshmand B, Tabibzadeh Z, Motamedian SR, Kouhestani F. Effectof metformin on dental pulp stem cells attachment, proliferation anddifferentiation cultured on biphasic bone substitutes. Arch Oral Biol.2018;(95):44-50.
28. Qin W, Chen JY, Guo J, Ma T, Weir MD, Guo D, et al. Novel calciumphosphate cement with metformin-loaded chitosan for odontogenicdifferentiation of human dental pulp cells. Stem Cells Int. 2018:1-10.
29. Boreak N, Khayrat NMA, Shami AO, et al. Metformin pre-conditioningenhances the angiogenic ability of the secretome of dental pulp stemcells. Saudi Pharmaceutical Journal. 2021;29(8): 908-913.
30. Luzuriaga J, Irurzun J, Irastorza I, Unda F, Ibarretxe G, Pineda JR.Vasculogenesis from human dental pulp stem cells grown in matrigelwith fully defined serum-free culture media. Biomedicines. 2020;8:483.
31. Kouhestani F, Rezai Rad M, Mohaghegh S, Motamedian SR. Effect ofmetformin on the behavior of dental pulp stem cells cultured on freeze-dried bone allografts. Dent Med Probl. 2021;58(3):343-349.
32. Zhang S, Zhang R, Qiao P, et al. Metformin-Induced MicroRNA-34a3pDownregulation alleviates senescence in human dental pulp stem cellsby targeting CAB39 through the AMPK/mTOR signaling pathway.Stem Cells Int. 2021;2021:1-13.
33. Stájer A, Kajári S, Gajdács M, Musah-Eroje A, Baráth Z. Utilityof photodynamic therapy in dentistry: current concepts. Dent J.2020;8(2):43.
34. Afrasiabi S, Pourhajibagher M, Bahador A. The photomodulationactivity of metformin against oral microbiome. J Lasers Med Sci.2019;10(3):241-250.
35. Coppola N, Mignogna MD, Rivieccio I, et al. Current knowledge,attitudes, and practice among health care providers in OSCC awareness:systematic review and meta-analysis. Int J Environ Res, 2021;18(9):4506.
36. Liu L, Chen J, Cai X, Yao Z, Huang J. Progress in targeted therapeuticdrugs for oral squamous cell carcinoma. Surg Oncol, 2019;(31):90-97.
37. Gutkind JS, Molinolo AA, Wu X, et al. Inhibition of mTOR signalingand clinical activity of metformin in oral premalignant lesions. JCIInsight. 2021;6(17):e147096.
38. Liu S, Shi C, Hou X, et al. Transcriptional and H3K27ac related genomeprofiles in oral squamous cell carcinoma cells treated with metformin. JCancer. 2022;21:13(6):1859-1870.
39. Guimarães TA, Farias LC, Santos ES, et al. Metformin increases PDHand suppresses HIF-1α under hypoxic conditions and induces cell deathin oral squamous cell carcinoma. Oncotarget. 2016;7(34):55057-55068.
40. Nicolini AC, Grisa TA, Muniz FW, Rösing CK, Cavagni J. Effect ofadjuvant use of metformin on periodontal treatment: a systematicreview and meta-analysis. Clin Oral Invest, 2019;23(6):2659-2666.
41. Akram Z, Vohra F, Javed F. Locally delivered metformin as adjunctto scaling and root planing in the treatment of periodontal defects: asystematic review and meta-analysis. J Periodontal Res, 2018;53(6):941-949
42. Araújo AA, Pereira ASBF, Medeiros CACX, et al. Effects of metforminon inflammation, oxidative stress, and bone loss in a rat model ofperiodontitis. PLoS One. 2017;12(8):e0183506.
43. Kominato H, Takeda K, Mizutani K, et al. Metformin accelerateswound healing by Akt phosphorylation of gingival fibroblasts ininsulin-resistant prediabetes mice. J Periodontol. 2022;93(2):258-270.
44. Donos N, Calciolari E, Brusselaers N, Goldoni M, Bostanci N,Belibasakis GN. The adjunctive use of host modulators in non-surgicalperiodontal therapy. A systematic review of randomized, placebo-controlled clinical studies. J Clin Periodontol. 2020;47(S22):199-238.
45. Bak EJ, Parkı HG, Kim M, et al. The effect of metformin on alveolarbone in ligature-induced periodontitis in rats: a pilot study. JPeriodontol. 2010;81(3):412-419.
46. Ikhar AS, Kolte RA, Kolte AP, Purohit AR, Dahake RN. Periodontalkemik kusurlarının tedavisinde metforminli ve metforminsiztrombosit açısından zengin fibrinin etkinliği: sistematik bir incelemeve meta- analiz. Acta Odontologica Scandinavica, 2023;81(3): 186-195.
47. Patil KS, Mahajani M, Choudhary SH, Aldhuwayhi SD, Thakare A,Mustafa MZ. Efficacy of 1.5% metformin gel as an adjuvant to scaling,root planing, and curettage for the Treatment of Infrabony defects inchronic periodontitis patients. Contemp Clin Dent. 2022;13(1):18-23.
48. Sun J, Du J, Feng W, et al. Histological evidence that metformin reversesthe adverse effects of diabetes on orthodontic tooth movement in rats. JMol Histol, 2017;48(2):73-81.
49. Inouye KA, Bisch FC, Elsalanty ME, Zakhary I, Khashaba RM, BorkeJL. Effect of metformin on periimplant wound healing in a rat model oftype 2 diabetes. Implant Dent. 2014;23(3):319-327.
50. Zhao X, Pathak JL, Huang W, et al. Metformin enhances osteogenicdifferentiation of stem cells from human exfoliated deciduous teeththrough AMPK pathway. J Tissue Eng Regen Med.2020;14(12):1869-1879.
51. Deng S, Lei T, Chen H, et al. Metformin pre-treatment of stem cellsfrom human exfoliated deciduous teeth promotes migration andangiogenesis of human umbilical vein endothelial cells for tissueengineering. Cytotherapy. 2022;24(11):1095-1104.